Skip to Content

Verdeso Approval History

FDA Approved: Yes (First approved September 19, 2006)
Brand name: Verdeso
Generic name: desonide
Dosage form: Foam
Company: Connetics Corporation
Treatment for: Dermatitis

Verdeso (desonide) Foam is a low-potency topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle for the treatment of mild-to-moderate atopic dermatitis.

Development History and FDA Approval Process for Verdeso

DateArticle
Sep 19, 2006Approval Verdeso Connetics Corporation - Treatment for Mild-to-Moderate Atopic Dermatitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide